MPM Asset Management Investors Bv4 LLC
CIK 0001358313 Name as filed on the most recent filing
Filed as MPM Asset Management Investors Bv4 LLC (16)
27 transaction lines · from 16 filings · filed 2007-01-05 to 2014-02-11 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
- ISSUER Epizyme, Inc. 1 filings
- ISSUER Conatus Pharmaceuticals Inc 1 filings
- ISSUER Pacira Pharmaceuticals, Inc. 4 filings
- ISSUER Peplin Inc 7 filings
- ISSUER Memory Pharmaceuticals Corp 3 filings
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
0 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2014-02-10 |
Epizyme, Inc. EPZM |
S, Open-market sale | 466,666 disposed | 29.25 | 13,649,980.50 | Form 4, filing 0001209191-14-009076 | |
| 2013-07-30 |
Conatus Pharmaceuticals Inc CNAT |
P, Open-market purchase | 165,265 acquired | 11.00 | 1,817,915.00 | Form 4, filing 0001209191-13-038625 | |
| 2013-03-11 |
Pacira Pharmaceuticals, Inc. PCRX |
S, Open-market sale | 500,000 disposed | 27.86 | 13,930,000.00 | Form 4, filing 0001209191-13-016170 | |
| 2011-11-21 |
Pacira Pharmaceuticals, Inc. PCRX |
P, Open-market purchase | 461,538 acquired | 6.50 | 2,999,997.00 | Form 4, filing 0001209191-11-057585 | |
| 2011-02-08 |
Pacira Pharmaceuticals, Inc. PCRX |
P, Open-market purchase | 267,857 acquired | 7.00 | 1,874,999.00 | Form 4, filing 0001209191-11-010540 | |
| 2011-02-08 |
Pacira Pharmaceuticals, Inc. PCRX |
P, Open-market purchase | 267,857 acquired | 7.00 | 1,874,999.00 | Form 4, filing 0001209191-11-010540 | |
| 2009-02-12 |
Peplin Inc PLIN |
P, Open-market purchase | 1,249 acquired | 8.20 | 10,241.80 | Form 4, filing 0001209191-09-008575 | |
| 2009-02-11 |
Peplin Inc PLIN |
P, Open-market purchase | 999 acquired | 8.00 | 7,992.00 | Form 4, filing 0001209191-09-008575 | |
| 2009-02-09 |
Peplin Inc PLIN |
P, Open-market purchase | 999 acquired | 8.00 | 7,992.00 | Form 4, filing 0001209191-09-007919 | |
| 2009-02-05 |
Peplin Inc PLIN |
P, Open-market purchase | 2,648 acquired | 7.80 | 20,654.40 | Form 4, filing 0001209191-09-007152 | |
| 2009-01-27 |
Peplin Inc PLIN |
P, Open-market purchase | 948 acquired | 8.00 | 7,584.00 | Form 4, filing 0001209191-09-005048 | |
| 2009-01-27 |
Peplin Inc PLIN |
P, Open-market purchase | 730 acquired | 8.40 | 6,132.00 | Form 4, filing 0001209191-09-005048 | |
| 2009-01-23 |
Peplin Inc PLIN |
P, Open-market purchase | 6,029 acquired | 8.00 | 48,232.00 | Form 4, filing 0001209191-09-005048 | |
| 2009-01-22 |
Peplin Inc PLIN |
P, Open-market purchase | 1,334 acquired | 8.00 | 10,672.00 | Form 4, filing 0001209191-09-004718 | |
| 2009-01-22 |
Peplin Inc PLIN |
P, Open-market purchase | 1,249 acquired | 8.20 | 10,241.80 | Form 4, filing 0001209191-09-004718 | |
| 2009-01-21 |
Peplin Inc PLIN |
P, Open-market purchase | 932 acquired | 8.00 | 7,456.00 | Form 4, filing 0001209191-09-004718 | |
| 2009-01-20 |
Peplin Inc PLIN |
P, Open-market purchase | 45 acquired | 8.40 | 378.00 | Form 4, filing 0001209191-09-003974 | |
| 2009-01-19 |
Peplin Inc PLIN |
P, Open-market purchase | 899 acquired | 8.20 | 7,371.80 | Form 4, filing 0001209191-09-003974 | |
| 2009-01-16 |
Peplin Inc PLIN |
P, Open-market purchase | 7,340 acquired | 8.20 | 60,188.00 | Form 4, filing 0001209191-09-003974 | |
| 2009-01-15 |
Peplin Inc PLIN |
P, Open-market purchase | 1,598 acquired | 7.80 | 12,464.40 | Form 4, filing 0001209191-09-003974 | |
| 2009-01-13 |
Peplin Inc PLIN |
P, Open-market purchase | 6,911 acquired | 7.03 | 48,584.33 | Form 4, filing 0001209191-09-003417 | |
| 2007-09-14 |
Memory Pharmaceuticals Corp MEMY |
S, Open-market sale | 27,600 disposed | 2.10 | 57,960.00 | Form 4, filing 0001209191-07-053963 | |
| 2007-09-13 |
Memory Pharmaceuticals Corp MEMY |
S, Open-market sale | 62,180 disposed | 2.12 | 132,120.06 | Form 4, filing 0001209191-07-053454 | |
| 2007-09-12 |
Memory Pharmaceuticals Corp MEMY |
S, Open-market sale | 10,000 disposed | 2.16 | 21,611.00 | Form 4, filing 0001209191-07-053454 | |
| 2006-12-18 |
Memory Pharmaceuticals Corp MEMY |
P, Open-market purchase | 2,315,151 acquired | 1.11 | 2,569,817.61 | Form 4, filing 0001181431-07-002396 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
- P, Open-market purchase
- Open-market purchase
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.
How to cite this page
ebomi catalog. MPM Asset Management Investors BV4 LLC, insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001358313
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6